Markets

Bruker Well Poised on Product Innovation amid Currency Woes

On Jun 14, we issued an updated research report on Billerica, MA-based Bruker CorporationBRKR − a global manufacturer of high-end analytical instruments used within the academic & government, pharma/biotech, clinical diagnostic and industrial markets. The company currently carries a Zacks Rank #3 (Hold).

Bruker started 2016 on a promising note, with its first-quarter results beating the Zacks Consensus Estimate on both fronts. A strong year-over-year revenue upside was driven by the company's enhanced operating performance and significant bottom-line improvement.

During the reported quarter, Bruker expanded its existing MALDI Biotyper workflow's menu to include selected high-value resistance testing for clinical microbiology research. The company also launched MBT Biotargets and introduced new research use-only capabilities to the MALDI Biotyper product portfolio.

Further, other products that the company recently launched include the honey profiling module of the NMR FoodScreener solution and the latest version of NMR wine screener module. Together these products are expected to contribute significantly to Bruker's revenues.

On the flip side, unfavorable currency translation continues to be a major dampener for the stock. Evidently, changes in foreign exchange rates impacted Bruker's revenues by 0.9% in the first quarter of 2016. For 2016, management expects revenues to face a 1.6% reduction owing to unfavorable currency.

Moreover, widespread macroeconomic uncertainties prevailing in countries like the U.S., Russia and certain European nations in which Bruker operates might hamper its revenue growth significantly, in case of any further economic downturn. Competitive headwinds also continue to pose threats to the stock.

Key Picks in the Sector

Better-ranked medical stocks are ICU Medical, Inc. ICUI , LeMaitre Vascular, Inc. LMAT and NuVasive, Inc. NUVA . All the three stocks carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

BRUKER CORP (BRKR): Free Stock Analysis Report

LEMAITRE VASCLR (LMAT): Free Stock Analysis Report

NUVASIVE INC (NUVA): Free Stock Analysis Report

ICU MEDICAL INC (ICUI): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ICUI NUVA LMAT BRKR

Other Topics

Stocks

Latest Markets Videos